CREATINE IS A NATURAL SUPPLEMENT USED TO BOOST ATHLETIC PERFORMANCE
It's been researched for more than 200 years and numerous studies support its safety for long-term use. Clinical trials lasting up to five years report no adverse effects in healthy individuals.
SSP CREATINE MONOHYDRATE 100% PHARMACEUTICAL GRADE has an undisputed ability to work in long term studies effectively and safely. SSP's superior quality Creatine Monohydrate allows for greater strength, quicker bursts of speed and faster recovery.
"IN ORDER FOR SSP'S CREATINE MONOHYDRATE TO BE DEEMED PHARMACEUTICAL GRADE, OUR PRODUCT EXCEEDS A PURITY LEVEL OF 99% WITH NO BINDERS, FILLERS, EXCIPIENTS, DYES, OR UNKNOWN SUBSTANCES"
Your Satisfaction is Backed by SSP Nutrition's 100% Money Back Guarantee
*HERE ARE 10 SCIENCE-BASED BENEFITS OF CREATINE:
1. Helps Muscle Cells Produce More Energy: Supplementing with creatine can provide additional ATP energy, which improves high-intensity exercise performance.
2. Supports Many Other Functions in Muscles: It can alter numerous cellular pathways that lead to new muscle growth, including boosting the formation of proteins that create new muscle fibers. It can also increase IGF-1 levels and stimulate the Akt/PKB pathway. These send a signal to your body to build muscle mass. Creatine Monohydrate can also increase the water content of your muscles. This is known as cell volumization, and can quickly increase the size of muscles.
- Strength
- Ballistic power
- Sprint ability
- Muscle endurance
- Resistance to fatigue
- Muscle mass
- Recovery
- Brain performance
Unlike supplements that only benefit advanced athletes, creatine provides benefits regardless of your fitness level. Reviews find it improves high-intensity exercise performance by up to 15%.
- Alzheimer's disease
- Ischemic stroke
- Epilepsy
- Brain or spinal cord injuries
Creatine has also shown benefits against ALS, a disease that affects the motor neurons essential for movement. It improved motor function, reduced muscle loss and extended the survival rate by 17%.